Research is used to build new knowledge, improve current care and develop new treatments. The National Institute for Health Research Clinical Research Network (often referred to as CRN) provide the infrastructure that allows high-quality clinical research to take place in the NHS.
All clinical research has to be approved by an independent research ethics committee - the Medicines and Healthcare Products Regulatory Agency (MHRA). This safeguards the rights and welfare of research participants as well as making sure that high quality research is carried out. All research is voluntary and participants are free to withdraw at any time.
The Women’s Health department at UCLH are committed to improving outcomes for women and babies by improving care, diagnosis and treatment within obstetrics and gynaecology. A small team of research doctors, assistants, midwives and nurses work on an extensive portfolio of CRN funded research studies that cover specialised areas including maternity, gynaecology, neonatal care, fertility, genetics, miscarriage, urogynaecology and cancer.
UCLH is a large teaching hospital and has many research projects underway at any one time. Whilst under our care you are likely to be invited to participate in a research project by healthcare professionals. This may be one of our consultants, nurses or midwives.
Alternatively, if you are interested in volunteering for any of our studies or just would like to have some more information please contact us.
In the unlikely event you encounter any problems or have any concerns about any of our research activity, please contact Yaa Acheampong, Research Manager at y.
For more information about our gynaecology and neonatal studies, please visit the pages below:
Current research studies
Aim:
- Developing a wearable placental monitoring device that non-invasively monitors placental function (oxygenation and metabolism) using a light technology called NIRS (Near- Infrared Spectroscopy), to reduce hypoxic brain injury and stillbirth.
Recruitment:
- Women ≥ 18 years old
- Singleton pregnancy
- ≥ 23 weeks gestation
Pilot study (June 2023- May 2024)
- Women with a 'normal' or 'low risk’ pregnancy
Main study (April 2024 onwards)
- Women who with a singleton pregnancy with risk factors including pre-eclampsia, pre-existing or gestational diabetes mellitus and reactive hypoglycemia, growth restricted/ small for gestational age fetus, infection or inflammation.
For more information, please see our patient information sheet here.
Aim:
- Investigate the role of T-regulatory (Treg) cell in maintaining a healthy pregnancy and influencing the development of pre-eclampsia.
Recruitment:
- All women in their first ongoing pregnancy
Additional information:
Aim:
- Establishing a registry of all UK twin pregnancies complicated by Twin to twin transfusion syndrome (TTTS) to answer uncertainties regarding the treatment and management.
Recruitment:
- All complicated multiple pregnancies, uncomplicated monochorionic twin pregnancies, Triplet pregnancies and any multiple pregnancy (twin or triplet) complicated by TTTS.
Additional information:
Aim:
- To create an adequately powered, detailed observational resource for the study of the environmental and genetic determinants of cleft lip/ palate, and the outcomes for patients and families affected by cleft lip/ palate
Recruitment:
- All children diagnosed (antenatally or postnatally) with a cleft and their families will be eligible to participate.
Additional information:
For more information about the Cleft Collective study, visit here.
Aim:
To find out whether it is possible to grow stem cells from amniotic fluid, placental tissue and fetal fluid, and whether proteins found in the fluid can be used to indicate long term outcome for problems such as kidney disease.
Recruitment:
Two groups of women are eligible to take part in this study:
- women having amniocentesis or chorionic villus sampling (CVS), fetal blood or urine sampling for prenatal diagnosis are eligible to participate in the study.
- women attending UCLH to give birth to their baby.
For more information about the amniotic fluid, placental and stem cells study, visit here.
Aim:
- To improve the quality of imaging from Magnetic Resonance Imaging (MRI) and ultrasound and use these to develop low risk techniques for diagnosis, treatment and therapy for a range of dangerous conditions of the baby during pregnancy.
Recruitment:
- Pregnant women recommended to have a fetal MRI due to fetal abnormality or pregnancy complications.
Additional information:
Aim:
- To look at new methods of detecting problems in pregnancy, in the hope of developing earlier and safer ways of identifying genetic conditions. Research has shown that a pregnant mother has some of her baby’s DNA and other substances in her own blood, so a simple blood sample from the mother can help us to detect any genetic conditions or chromosomal problems in the unborn baby.
Recruitment:
- Women with normal and complicated pregnancies are asked to donate a blood sample of 20-30mls. In addition to this, where it is possible, we are also asking partners to donate about 10mls of their blood, so we can better define the baby’s DNA from the mother’s.
Additional information:
For more information visit: http:/
Aim:
To investigate how bacteria in the vagina and urine may help current tools (e.g. cervical length and fetal fibronectin) to best predict preterm birth in twins. We specifically aim to investigate twin pregnancies undergoing an intervention such as fetal laser surgery, as well as those undergoing a cervical cerclage.
Recruitment:
- Uncomplicated singleton and twin pregnancy
- Singleton pregnancy have had a prior spontaneous PTB before 34 weeks
- Singleton or twin pregnancy at risk of preterm birth, requiring a clinically indicated cervical cerclage
- Monochorionic twin pregnancy identified to have twin-twin transfusion syndrome (TTTS) or selective fetal growth restriction (sFGR) requiring fetoscopic
Additional information:
Aim:
- To compare carboprost with oxytocin as initial treatments for women with clinically.
- To assess the relative cost-effectiveness of the use of carboprost and oxytocin as initial treatments for women with clinically diagnosed PPH.
- To explore the views of participants and their carers about their experiences of the two treatments and the consent process.
Recruitment:
- ≥ 16 years of age
- Requirement for medical treatment for primary PPH
Additional information:
Aim:
To establish the optimum method of timing delivery in late-preterm fetal growth restriction.
Recruitment:
- Women ≥ 18 years old
- pregnant with singleton non-anomalous fetuses
- between 32+0 and 36+6 weeks of gestation
- estimated fetal weight or abdominal circumference <10th percentile OR decreased by
- 50 percentiles since an ultrasound scan at 18+0-32+0 weeks and:
- cerebral redistribution defined as UCR >1.0 (32+0-33+6 weeks) or >0.8 (34+0-36+6 weeks) repeated within 2-24 hours
- normal STV on cCTG (4.5msec or above)
Additional information:
Aim:
- Improve our knowledge and understanding of the caesarean section scar effect, by assessing the healing of the scar using ultrasound imaging. To compare the imaging findings with future pregnancy outcomes.
Recruitment:
- Women over 18 years old with a previous emergency lower segment caesarean section.
Additional information:
Aim:
- To determine if emergency cervical cerclage (operation to tie the neck of the womb closed when it has started to open too early in pregnancy) can help prevent pregnancy loss, reduce preterm birth and is safe for mothers and babies
Recruitment:
- Pregnant women 16 years or older between 16 and 28 weeks of pregnancy who have an open cervix (neck of the womb) and the bag of eaters around baby is visible.
Additional information:
Aim:
- To collect tissue from a variety of developing fetal organs in the last two-thirds of pregnancy from women who decide to undergo a termination of pregnancy and who wish to undergo a clinical fetal post-mortem (PM) examination.
Recruitment:
- ≥18 years old pregnant women who attend the Fetal Medicine Unit for concerns about a fetal abnormality where they decide to proceed to termination of pregnancy.
- Written informed consent obtained (sought after the clinical decision to TOP and signatures for termination are obtained).
- >14 weeks gestation live pregnancy shown by ultrasound scan.
- Known low risk for HIV, Hepatitis B and Hepatitis C infections.
Additional information:
For more information on this study, please visit the link here.
Aim:
To provide a better understanding of the roles of stigma and discrimination on the health and wellbeing of LGBTQIA+ gestational parents during their pregnancy and birth along with the health and wellbeing of their infants, compared to their cisgender heterosexual peers.
Recruitment:
Patients must meet all of the following in order to be eligible for the study:
- Legal adult of reproductive age (18-49)
- Identifies as a lesbian, gay, bisexual, queer, nonbinary, intersex, and/or transgender (or cisgender and heterosexual for comparison sample)
- Currently pregnant and receiving antenatal care
Additional information:
Aim:
- To evaluate the effect of different antihypertensive drugs in woman with pregnancy hypertension on maternal and fetal/neonatal outcomes.
Recruitment:
- Pregnancy between 11+0 and 34+6 weeks’ gestation inclusive
- Diagnosis of pregnancy hypertension (chronic/gestational hypertension or pre-eclampsia)
- Clinical decision to initiate or continue use of antihypertensive drugs
- Aged 18 years or over
Additional information:
Aim:
- Sometimes at the end of labour a doctor may need to help turn the baby, so their head is in the best position for birth. The aim of this trial to investigate the best method to do this; either by manual rotation (by hand) or by using an instrument (forceps or suction cup). We are looking at which method improves the short- and long-term outcomes for mothers and babies as well as the birth experience.
Recruitment:
- ≥16 years of age at time of randomisation
- Singleton pregnancy
- ≥36 weeks’ gestation where the baby is in a ‘back-to-back’ position or looking sideways that requires turning.
Additional information:
Aim:
- The Rainbow Clinic aims to provide specialist care and support to families who have experienced the loss of a baby during pregnancy or shortly afterwards. The first established clinic offering care to parents who have experienced loss has witnessed improvement in the pregnancy outcomes and patient experience. As this is a new clinical service in most hospitals, we would like to evaluate the care provided in the clinics across the United Kingdom, to look at where care can be improved; your experiences will help to do this.
Recruitment:
- Women who are attending a Rainbow Clinic or equivalent which specialises in care in pregnancy after stillbirth or neonatal death.
Additional information:
Research Champions
The National Institute for Health Research are recruiting volunteer Research Champions to help spread the word about health research.
Being a Research Champion
You can be a Research Champion if you are passionate about making sure people get the best treatment possible in the future. You don't have to have been part of health research to get involved and make a difference.
- You can commit as much or as little time as you like
- You will have access to free training and support
- You will be part of national network of volunteers and find out about other opportunities to make a difference
- You will be invited to events and get to meet others in your community, and health professionals and researchers.
Want to get involved?
If you are interested in becoming a research champion or finding out more, please get in touch with your local contact: www.nihr.ac.uk/researchchampions
Women's Health Research PRES Data Report
Participants of research studies within the Women’s Health department at UCLH were asked to take part in the Patient Research Experience Survey (PRES), as a part of the wider NIHR patient satisfaction project. Results of this survey are detailed in this report.
